The researchers at Rome's Spallanzani Hospital claimed that they developed the world’s first vaccine which neutralizes the virus and that the initial outcomes in animal studies were encouraging and beyond anticipations.
Moreover, the scientists also stated that this vaccine could also adapt to evolutions and mutations in COVID-19.
Human clinical trials for this vaccine could commence in the upcoming months in Italy.